MET and Miyoshi myopathy: Upon binding of HGF, C-MET dimerizes and initiates the processes that promote cell growth, migration and angiogenesis while inhibiting apoptosis, ultimately enhancing the development of MM.395 SL1 is the truncated form of the original CLN0003 ssDNA aptamer.